MLchartDataset catalogue

protein-bound paclitaxel

Term · Oncology and biomedicine · MLC-T-ONC-007009

A form of the anticancer drug paclitaxel that is used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. Protein-bound paclitaxel may have fewer side effects and work better than other forms of paclitaxel. It is also being studied in the treatment of other types of cancer. Protein-bound paclitaxel stops cancer cells from growing and dividing and may kill them. It is a type of taxane. Also called ABI-007, Abraxane, nanoparticle paclitaxel, and paclitaxel albumin-stabilized nanoparticle formulation.

Table 1. Record
IdentifierMLC-T-ONC-007009
FieldOncology and biomedicine
SynonymsABI-007; Abraxane; nanoparticle paclitaxel; paclitaxel albumin-stabilized nanoparticle formulation
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007009",
  "term": "protein-bound paclitaxel",
  "field": "Oncology and biomedicine",
  "definition": "A form of the anticancer drug paclitaxel that is used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. Protein-bound paclitaxel may have fewer side effects and work better than other forms of paclitaxel. It is also being studied in the treatment of other types of cancer. Protein-bound paclitaxel stops cancer cells from growing and dividing and may kill them. It is a type of taxane. Also called ABI-007, Abraxane, nanoparticle paclitaxel, and paclitaxel albumin-stabilized nanoparticle formulation.",
  "synonyms": [
    "ABI-007",
    "Abraxane",
    "nanoparticle paclitaxel",
    "paclitaxel albumin-stabilized nanoparticle formulation"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/protein-bound-paclitaxel/"
}

Record 13,763 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.